Showing 20 of 102 recruiting trials for “perihilar-cholangiocarcinoma”
Enrolling by InvitationNCT05429190 ↗
Validation of SMS Protocol for HCC Screening in High-risk Patients
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
👨⚕️ Fei Li, M.D, The First Affiliated Hospital of Nanchang University📍 1 site📅 Started Sep 2023View details ↗
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Sep 2023View details ↗
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
RecruitingNCT06899854 ↗
Collection of Blood and Tissue Samples From Patients With Primary Liver Cancer.
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
The Application of Serum DNA Methylation for Patients With HCC
👨⚕️ Po-Yueh Chen, M.D, Ditmanson Medical Foundation Chiayi Christian Hospital📍 1 site📅 Started Mar 2023View details ↗
Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy
👨⚕️ Albrecht Hoffmeister, Prof.Dr.med., Universitätsklinikum Leipzig; Bereich Gastroenterologie📍 20 sites📅 Started Feb 2023View details ↗
Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
👨⚕️ Rutger-Jan Swijnenburg, MD, PhD, Amsterdam UMC, location AMC📍 1 site📅 Started Feb 2023View details ↗
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
👨⚕️ Chao Liu, PhD, Department of Biliary and Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University📍 1 site📅 Started Jan 2023View details ↗
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
TARGETed Therapy Drug MONITOring in DIGestive Oncology
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →